Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedNew revision v3.3.4 was added to the study record history, and revision v3.3.3 was removed, reflecting a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- The changes consist of a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer; these updates do not alter core trial data, eligibility, locations, or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedThe History page now shows a new revision entry (v3.3.2) added and the previous revision (v3.3.1) removed; no changes to the study data, status, or visible content are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 in the Record History for NCT05162443.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding notice about potential updates and operating status from the page header. This change does not affect core study information or navigation.SummaryDifference0.8%

- Check75 days agoChange DetectedThe new screenshot shows a slightly reorganized header and updated Record History layout, with the study title, sponsor, and version dates unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.